Skip to main content
SpringerLink
Log in

Nonsteroidal Anti-Inflammatory Drugs and Acute Renal Failure in the Elderly

A Risk-Benefit Assessment

  • Review Article
  • Adverse Effects
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most valuable groups of available medications because of their effectiveness in relieving pain, particularly that associated with rheumatoid arthritis. They are also among the most commonly prescribed drugs and, because of their availability over-the-counter, they are among the most widely consumed agents, especially by elderly people.

Older individuals are more predisposed to the renal adverse effects of NSAIDs, because of: (i) age-associated changes in renal function; (ii) the prevalence of comorbid conditions (congestive heart failure, hypertension, hepatic cirrhosis, renal insufficiency); and (iii) the pervasive use of concomitant drugs that affect kidney function (diuretics, antihypertensives). However, because the incidence of NSAID-induced acute renal failure (ARF) is relatively low, and because it occurs in an identifiable and therefore preventable setting, the benefits of limited NSAID use outweigh the risks of this adverse effect. Using NSAIDs for a restricted period of time at the lowest effective dosage, and informing patients of the conditions in which ARF can occur, should minimise the risk of this effect. If the use of an NSAID in a patient at potential risk of ARF is necessary, close monitoring of renal function should further reduce the already low risk: benefit ratio for this adverse effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roy FH, Russel C, editors. The encyclopedia of aging and the elderly. New York: Facts on File, 1992: 48–9

    Google Scholar 

  2. Jones AC, Berman P, Doherty M. Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions. Br J Rheumatol 1980; 31: 45–8

    Article  Google Scholar 

  3. Henry D, Dobson A, Turner C, et al. Variability in the risk of major gastrointestinal complications from nonaspirin nonste-roidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078–88

    PubMed  CAS  Google Scholar 

  4. Eknoyan G. Tubulointerstitial nephropathies. In: Martinez-Maldonado M, editor. Hypertension and renal disease in the elderly. Boston: Blackwell Scientific Publications, 1992: 225–41

    Google Scholar 

  5. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984; 26: 861–8

    Article  PubMed  CAS  Google Scholar 

  6. Lindeman RD. Hypertension and the kidney. Nephron 1987; 47 Suppl. 1: 62–7

    Article  PubMed  Google Scholar 

  7. Riser BL, Cortes P, Zhao X, et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90: 1932–43

    Article  PubMed  CAS  Google Scholar 

  8. McDonald RK, Solomon DH, Shock NW. Aging as a factor in the renal hemodynamic changes induced by standardized py-rogen. J Clin Invest 1951; 5: 457–62

    Article  Google Scholar 

  9. Pelz KS, Gottfried PE. Kidney function studies in old men and women. Geriatrics 1965; 20: 145–9

    PubMed  CAS  Google Scholar 

  10. McLachlan MSF. The aging kidney. Lancet 1978; II: 143–6

    Article  Google Scholar 

  11. Epstein M. Effects of aging on the kidney. Fed Proc 1979; 38: 168–72

    PubMed  CAS  Google Scholar 

  12. Brown W, Davis BB, Apry LA, et al. Aging and the kidney. Arch Intern Med 1986; 146: 1790–6

    Article  PubMed  CAS  Google Scholar 

  13. Anderson S, Brenner BM. The aging kidney: structure, function, mechanisms and therapeutic implications. J Am Geriatr Soc 1987; 35: 590–3

    PubMed  CAS  Google Scholar 

  14. Beck LE. Kidney function and disease in the elderly. Hosp Pract 1988; 15: 75–90

    Google Scholar 

  15. Darmady EM, Offer J, Woodhouse MA. The parameters of the aging kidney. J Pathol 1973; 109: 195–207

    Article  PubMed  CAS  Google Scholar 

  16. Sworn MJ, Fox M. Renal age change in the rat compared with human renal senescence: an autoradiography study. Invest Urol 1974; 12: 140–5

    PubMed  CAS  Google Scholar 

  17. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glo-meruli in the normal kidney, related to age and sex. Virchows Arch A Pathol Anat Histopathol 1980; 387: 271–7

    Article  CAS  Google Scholar 

  18. Haley DP, Bulger RE. The aging male rat: structure and function of the kidney. Am J Anat 1983; 167: 1–13

    Article  PubMed  CAS  Google Scholar 

  19. Lindeman RD, Lee TD, Yiengst MJ, et al. Influence of age, renal disease, hypertension, diuretics, and calcium on the antidi-uretic responses to suboptimal infusions of vasopressin. J Lab Clin Med 1966; 68: 206–22

    PubMed  CAS  Google Scholar 

  20. Epstein M, Hollenberg NM. Age as a determinant of oral sodium conservation in normal man. J Lab Clin Med 1976; 87: 411–2

    PubMed  CAS  Google Scholar 

  21. Adler S, Lindeman RD, Yiengst MJ, et al. Effect of acute acid loading on urinary acid excretion of the aging human kidney. J Lab Clin Med 1968; 72: 278–89

    PubMed  CAS  Google Scholar 

  22. Davies DF, Shock NW. Age changes in glomerular filtration, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496–507

    Article  PubMed  CAS  Google Scholar 

  23. Miller JH, McDonald RK, Shock NW. Age changes in the maximal rate of renal tubular reabsorption of glucose. J Gerontol 1952; 7: 196–200

    PubMed  CAS  Google Scholar 

  24. Eknoyan G. Current status of chronic analgesic and nonsteroi-dal antiinflammatory drug nephropathy. Curr Opin Nephrol Hypertens 1994; 3: 182–8

    Article  PubMed  CAS  Google Scholar 

  25. Murray M, Black P, Kuzmik D, et al. Acute and chronic effects of NSAIDs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 31(5): 188–97

    Article  Google Scholar 

  26. Brater DC, Anderson SA, Brown-Cartwright D, et al. Effect of etodolac in patients with moderate renal impairment compared with normal subjects. Clin Pharmacol Ther 1985; 38: 674–9

    Article  PubMed  CAS  Google Scholar 

  27. Toto RD, Anderson SA, Brown-Cartwright D, et al. Effects of acute and chronic NSAIDs in patients with renal insufficiency. Kidney Int 1986; 80: 760–8

    Article  Google Scholar 

  28. Murray MD, Green PK, Brater DC, et al. Effects of flurbiprofen on renal function in patients with moderate renal insufficiency. Br J Clin Pharmacol 1992; 33: 386–93

    Article  Google Scholar 

  29. Carmichael J, Shankel SW. Effects of non-steroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985; 78: 992–1000

    Article  PubMed  CAS  Google Scholar 

  30. Kjellstrand C, Leither T, Koehn J, et al. Iatrogenic renal disease. Arch Intern Med 1991; 151: 1809–12

    Article  PubMed  Google Scholar 

  31. Eknoyan G. Acute renal failure associated with tubulointersti-tial nephropathies. In: Brenner BM, Lazarus JM, editors. Acute renal failure. 2nd ed. New York: Churchill Livingston, 1988: 491–534

    Google Scholar 

  32. Porile J, Bakris G, Garella S. Acute interstitial nephritis with glomerulopathy due to NSAID agents: a review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol 1990; 30: 468–75

    PubMed  CAS  Google Scholar 

  33. Radford Jr MG, Holley KE, Grande JP, et al. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 1996 Aug 14; 276: 466–9

    Article  PubMed  CAS  Google Scholar 

  34. Palmer BF. Renal complications associated with non-steroidal anti-inflammatory agents. J Invest Med 1995; 43(6): 516–32

    CAS  Google Scholar 

  35. D’Elia J, Merino M, Rolla A, et al. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen. Ann Intern Med 1980; 92: 72–3

    PubMed  Google Scholar 

  36. Seelig C, Maloley P, Campbell J. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. South Med J 1990; 83(10): 1144–7

    Article  PubMed  CAS  Google Scholar 

  37. Clark BA, Shannon RP, Rosa RM, et al. Increased susceptibility to thiazine-induced hyponatremia in the elderly. J Am Soc Nephrol 1994; 5: 1106–11

    PubMed  CAS  Google Scholar 

  38. Lamiere N, Matthys E, Vanholder R, et al. Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant 1987; 2: 316–22

    Google Scholar 

  39. Fullerton T, Sica D, Blum R. Evaluation of the renal protective effect of misoprostol in elderly osteoarthritic patients at risk for NSAID-induced renal dysfunction. J Clin Pharmacol 1993; 33: 1225–32

    PubMed  CAS  Google Scholar 

  40. Boers M, Dijkmans BAC, Breedveld FC, et al. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. Br J Rheum 1991; 30: 56–9

    Article  CAS  Google Scholar 

  41. Antillon M, Cominelli F, Lo S, et al. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. J Rheumatol 1990; 17: 46–9

    Google Scholar 

  42. Whelton A, Strout R, Spilman P, et al. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990; 112: 568–76

    PubMed  CAS  Google Scholar 

  43. Simon LS, Basch CM, Young DY, et al. Effects of naproxen on renal function in older patients with mild to moderate renal dysfunction. Br J Rheumatol 1992; 31: 163–8

    Article  PubMed  CAS  Google Scholar 

  44. Eriksson LO, Sturfelt G, Thysell H, et al. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med 1990; 89: 313–21

    Article  PubMed  CAS  Google Scholar 

  45. Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983; 143: 1130–4

    Article  PubMed  CAS  Google Scholar 

  46. Hale W, May F, Marks R, et al. Renal effects of NSAIDs in the elderly. Curr Ther Res 1989; 46(1): 173–9

    Google Scholar 

  47. Swainson CP, Griffiths P, Watson ML. Chronic effects of oral sulindac on renal haemodynamics and hormones in subjects with chronic renal disease. Clin Sci 1986 Mar; 70(3): 243–7

    PubMed  CAS  Google Scholar 

  48. Ciabattoni G, Cinotti G, Pierucci A, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 1984; 310: 279–83

    Article  PubMed  CAS  Google Scholar 

  49. Quintero E, Gines P, Arroyo V, et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 1986; 42: 298–303

    Article  PubMed  CAS  Google Scholar 

  50. Schnitzer T, Moskowitz R, Griffin M, et al. Guidelines for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 1995; 38: 1535–46

    Article  PubMed  Google Scholar 

  51. Henrich WL, Agodoa LE, Barrett B, et al. National Kidney Foundation Position Paper. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 1996; 27: 162–5

    Article  PubMed  CAS  Google Scholar 

  52. Wendland M, Wagoner R, Holley VS. Renal failure associated with fenoprofen. Mayo Clin Proc 1980; 55: 103–7

    PubMed  CAS  Google Scholar 

  53. Fienfeld D, Olesnicky L, Pirani C, et al. Nephrotic syndrome associated with use of NSAIDs. Nephron 1984; 37: 174–9

    Article  Google Scholar 

  54. Brezin J, Moriberkatz S, Schwartz A, et al. Reversible renal failure and nephrotic syndrome associated with NSAIDs. N Engl J Med 1979; 301: 1271–3

    Article  PubMed  CAS  Google Scholar 

  55. Finkelstein A, Fraley D, Stachura J, et al. Fenoprofen nephrop-athy: lipoid nephrosis and interstitial nephritis. Am J Med 1982; 72: 81–7

    Article  PubMed  CAS  Google Scholar 

  56. Handa P. Renal effects of fenoprofen [letter]. Ann Intern Med 1980; 93: 508

    Google Scholar 

  57. Hannedouche T, Fournier J, Moore N, et al. Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen [letter]. Clin Nephrol 1986; 25: 314

    PubMed  CAS  Google Scholar 

  58. Furey S, Vargas R, McMahon F. Renovascular effects of non-prescription ibuprofen in elderly hypertensive patients with renal impairment. Pharmacotherapy 1993; 13: 143–8

    PubMed  CAS  Google Scholar 

  59. Gurwitz J, Avorn J, Degnan D, et al. Nonsteroidal anti-inflammatory drug associated azotemia in the very old. JAMA 1990; 264(4): 471–5

    Article  PubMed  CAS  Google Scholar 

  60. Murray M, Brater C, Tierney W, et al. Ibuprofen associated renal impairment in a large general internal medicine practice. Am J Med Sci 1990; 299(4): 222–9

    Article  PubMed  CAS  Google Scholar 

  61. Kharasch M, Johnson K, Strange G. Cardiac arrest secondary to indomethacin-induced renal failure: a case report. J Emerg Med 1990; 8: 51–4

    Article  PubMed  CAS  Google Scholar 

  62. Tan SY, Shapiro R, Kish MA. Reversible acute renal failure induced by indomethacin. JAMA 1979; 241: 2732–3

    Article  PubMed  CAS  Google Scholar 

  63. Fawaz-Estrup F, Ho Jr G. Reversible acute renal failure induced by indomethacin. Arch Intern Med 1981; 141: 1670–1

    Article  PubMed  CAS  Google Scholar 

  64. Galler M, Folkert VW, Schlondorff DO. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA 1981; 246: 154–5

    Article  PubMed  CAS  Google Scholar 

  65. MacCarthy EP. Indomethacin-induced hyperkalemia. Med J Aust 1979; 1: 550

    PubMed  CAS  Google Scholar 

  66. Kimberly RP, Brandstetter RD. Exacerbation of phenylbutaz-one related renal failure by indomethacin. Arch Intern Med 1978; 138: 1711–2

    Article  PubMed  CAS  Google Scholar 

  67. Schoch P, Ranno A, North D. Acute renal failure in an elderly woman following intramuscular ketorolac administration. Ann Pharm 1992; 26: 1233–5

    CAS  Google Scholar 

  68. Adverse Drug Reactions Advisory Committee. Ketorolac and renal failure. Med J Aust 1993; 159: 488

    Google Scholar 

  69. Pearce C, Gonzalez FM, Wallin D. Renal failure and hyperkalemia associated with ketorolac. Arch Intern Med 1993; 53: 1000–2

    Article  Google Scholar 

  70. Boras-Uber L, Brackett N. Ketorolac induced acute renal failure. Am J Med 1992; 92: 450–2

    Article  PubMed  CAS  Google Scholar 

  71. Haragsim L, Dalai R, Baffa H, et al. Ketorolac induced acute renal failure and hyperkalemia: report of 3 cases. Am J Kidney Dis 1994; 24: 578–80

    PubMed  CAS  Google Scholar 

  72. Perazella M, Bulla G. NSAID nephrotoxicity revisited: acute renal failure due to parenteral ketorolac. South Med J 1993; 86: 1421–4

    Article  PubMed  CAS  Google Scholar 

  73. Corelli R, Gericke K. Renal insufficiency associated with intramuscular administration of ketorolac. Ann Pharmacother 1993; 27: 1055–7

    PubMed  CAS  Google Scholar 

  74. Fong J, Gora M. Reversible renal insufficiency following ketorolac therapy. Ann Pharmacother 1993; 27: 510–2

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Nephrology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, Texas, 77030, USA

    Wadad Ailabouni &  Garabed Eknoyan

Authors
  1. Wadad Ailabouni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garabed Eknoyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ailabouni, W., Eknoyan, G. Nonsteroidal Anti-Inflammatory Drugs and Acute Renal Failure in the Elderly. Drugs & Aging 9, 341–351 (1996). https://doi.org/10.2165/00002512-199609050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199609050-00005

Keywords

Search

Navigation